Health Encyclopedia

Mesoridazine

Mesoridazine: Uses, Dosage, Side Effects, Interactions

Introduction to Mesoridazine

Mesoridazine, also known by its brand name Serentil, is an antipsychotic medication primarily used to treat schizophrenia. It belongs to the phenothiazine class of drugs and acts as a dopamine antagonist in the central nervous system (CNS). Mesoridazine has been used in the treatment of various psychiatric disorders since its introduction in the 1950s.

Chemical Information

Mesoridazine has the chemical formula C21H26N2OS2 and is identified by the CID number 4078. Its chemical structure consists of a phenothiazine ring system with a piperidine ring attached at the 10-position. Mesoridazine is the active metabolite of thioridazine, another antipsychotic drug.

Physical and Chemical Properties

Mechanism of Action

Mesoridazine acts as an antagonist at various neurotransmitter receptors in the CNS, primarily targeting dopamine receptors. By blocking dopamine receptors, mesoridazine helps to reduce the positive symptoms of schizophrenia, such as hallucinations and delusions. It also has antagonistic effects on serotonin and histamine receptors, contributing to its therapeutic and side effect profile.

Comparison with Other Phenothiazines

Mesoridazine shares similarities with other phenothiazine antipsychotics, such as chlorpromazine and thioridazine. However, it has a lower potency compared to some other phenothiazines and may have a slightly different side effect profile. Mesoridazine is considered a low-potency antipsychotic.

Pharmacology

Pharmacodynamics

Mesoridazine‘s primary pharmacological action is the antagonism of dopamine D2 receptors in the mesolimbic and mesocortical pathways of the brain. This action is believed to be responsible for its antipsychotic effects. Mesoridazine also has antagonistic effects on other neurotransmitter receptors, including serotonin 5-HT2A and histamine H1 receptors.

Pharmacokinetics

Mesoridazine is well absorbed orally and undergoes extensive first-pass metabolism in the liver. It has a half-life of approximately 24 hours and is primarily metabolized by the cytochrome P450 enzyme system. The drug and its metabolites are mainly excreted in the urine. Studies have shown that the pharmacokinetics of mesoridazine can be affected by factors such as age, liver function, and concomitant medications.

Medical Uses

Mesoridazine is primarily indicated for the treatment of schizophrenia, particularly in patients who have not responded adequately to other antipsychotic medications. It may also be used in the management of other psychiatric conditions, such as:

Mesoridazine has been shown to be effective in reducing positive symptoms of schizophrenia, such as hallucinations, delusions, and disordered thinking. It may also help alleviate negative symptoms, although its efficacy in this regard is less pronounced compared to newer atypical antipsychotics.

Dosage and Administration

The usual starting dose of mesoridazine for the treatment of schizophrenia in adults is 50-100 mg per day, given in divided doses. The dosage may be gradually increased based on individual patient response and tolerability. The maximum recommended daily dose is 400 mg.

Dosage Adjustments

Dosage adjustments may be necessary for certain patient populations, such as the elderly, those with renal or hepatic impairment, or patients taking concomitant medications that may interact with mesoridazine. In elderly patients, a lower starting dose and slower titration are generally recommended to minimize the risk of adverse effects.

Forms of Administration

Mesoridazine is available in oral tablet and capsule formulations. It should be taken with food to minimize gastrointestinal side effects. Patients should be counseled on the importance of medication adherence and regular follow-up with their healthcare provider.

Interactions

Drug Interactions

Mesoridazine may interact with various medications, including:

These interactions can lead to increased or decreased levels of mesoridazine or the interacting drug, resulting in altered therapeutic effects or an increased risk of adverse reactions. Healthcare providers should carefully review a patient’s medication list and adjust dosages as needed when prescribing mesoridazine.

Food Interactions

Food does not significantly affect the absorption of mesoridazine. However, taking the medication with food may help reduce gastrointestinal side effects, such as nausea and vomiting.

Side Effects and Risks

Mesoridazine can cause a range of side effects, some of which may be serious or life-threatening. Common side effects include:

Serious Side Effects

Mesoridazine may cause serious side effects, such as:

Patients should be monitored closely for any signs of these serious adverse effects, and mesoridazine should be discontinued if they occur.

Contraindications

Mesoridazine is contraindicated in patients with a known hypersensitivity to the drug or any of its components. It should also be avoided in patients with a history of QT prolongation, recent acute myocardial infarction, or uncompensated heart failure. Caution should be exercised when prescribing mesoridazine to patients with seizure disorders, hepatic or renal impairment, or those at risk for aspiration pneumonia.

Patient Populations

Pregnancy and Breastfeeding

Mesoridazine is classified as a Category C drug by the FDA, indicating that animal studies have shown adverse effects on the fetus, but there are no adequate human studies. The drug should only be used during pregnancy if the potential benefits outweigh the risks. Mesoridazine is excreted in human milk and may cause adverse effects in nursing infants. Breastfeeding should be avoided during treatment with mesoridazine.

Children and Elderly Patients

The safety and efficacy of mesoridazine in children have not been established. Its use in pediatric patients is not recommended. Elderly patients may be more susceptible to the adverse effects of mesoridazine, particularly anticholinergic effects, orthostatic hypotension, and extrapyramidal symptoms. Lower starting doses, slower titration, and careful monitoring are advised in this population.

Contraindications and Precautions

Contraindications

Mesoridazine is contraindicated in patients with:

Precautions

Precautions should be taken when prescribing mesoridazine to patients with:

Patients should be monitored closely for any worsening of their condition or the emergence of new symptoms. Regular assessments of therapeutic response, adverse effects, and medication adherence are essential for ensuring the safe and effective use of mesoridazine.

Mesoridazine